mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.6 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.029 |
0.6 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.6 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |